Pharmaceutical composition

CAFC
  • US 7,935,690 B2
  • Filed: 10/30/2007
  • Issued: 05/03/2011
  • Est. Priority Date: 04/19/2002
  • Status: Active Grant
First Claim
Patent Images

1. A method for maintaining a therapeutically effective concentration of an androgen in the blood serum of a male for treating of hypogonadism which comprises transdermally delivering to the male by applying to the skin a composition which is in the form of a topical gel, which has a viscosity of about 500 to about 20,000 cps and a pH of about 3 to about 9, and comprises:

  • (A) about 0.1 to about 5 wt. % of an androgen selected from the group consisting of testosterone, DHEA (dehydroepiandrosterone), pregnenolone, progesterone, 17-OH-progesterone, and androsterone;

    (B) about 8 to about 25 wt. % of a macrocyclic enhancer selected from the group consisting of 3-methylcyclopentadecanone, 9-cycloheptadecen-1-one, cyclohexadecanone, cyclopentadecanone, oxacyclohexadecan-2-one and mixtures thereof; and

    (C) about 0.1 to about 10 wt. % of a thickening agent;

    (D) a mixture of solvents which include about 40 wt. % to about 80% of ethanol.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×